Research on an Alzheimer’s Disease Blood Test Is Expanding

Researchers in Florida are working together to increase the number of blood tests being developed for Alzheimer’s disease.

Director of the Wien Center for Alzheimer’s Disease and Memory Disorders that Mount Sinai Medical Centers, neurologist Dr. Ranjan Duara, was a member of the team that discovered beta amyloid biomarkers in blood samples well in advance of the biomarkers causing plaque to form in the brain.

“We looked at the relationship between the levels of amyloid in the blood to the PET scan which shows the amyloid plaques in the brain and what we found is it was 90 percent correct in detecting amyloid in the PET scan the blood test,” Duara said.

According to him, a straightforward blood test with high accuracy might be utilized as a screening tool for the general public, enabling medical professionals to identify and treat Alzheimer’s disease early on.

MEDICATION MAY REDUCE THE RISK OF DEATH FROM ADHD

According to a significant Swedish study, prescribing medication for ADHD may help lower patients’ overall mortality risk.

After following around 150,000 individuals with ADHD diagnoses, researchers discovered that receiving treatment reduced the two-year mortality rate for those individuals by 19%.

The necessity of prompt diagnosis of ADHD is emphasized in the report, according to experts.

THE US’S MATERNAL HEALTH CRISIS IS INQUIRED

The stated scope of the maternal health problem in the United States has also been questioned by a recent study that was published on March 13, 2024 in the American Journal of Obstetrics and Gynecology.

It was proposed that the pregnancy checkbox on death certificates, which does not specify whether the pregnancy was a contributing factor in the woman’s death, may have caused an overestimation of maternal deaths.

Therefore, contrary to what federal statistics implies, maternal death rates in the United States may really be lower and more steady.